GH

Guardant Health, Inc. is a pioneering precision oncology company at the forefront of innovation in cancer diagnostics, focusing on advanced blood tests for early cancer detection and monitoring through comprehensive genomic profiling. Based in Redwood City, California, Guardant Health utilizes proprietary technologies and vast data analytics to empower healthcare providers and patients with actionable insights that enhance treatment effectiveness and improve clinical outcomes. With a commitment to transforming cancer care on a global scale, the company is well-positioned to lead the way in precision medicine, addressing the evolving needs of patients and the healthcare ecosystem.